Magnay, Julia L.
O’Brien, Shaughn
Gerlinger, Christoph
Seitz, Christian http://orcid.org/0000-0003-2315-9148
Funding for this research was provided by:
Bayer (NA)
Article History
Received: 8 April 2019
Accepted: 16 January 2020
First Online: 10 February 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: J.L.M. has received payment for consulting and medical writing services from Bayer AG for this and other work. S.O’B. has received a grant to his institution from Bayer AG for menstrual pictogram research and from Advantage West Midlands (a company involved in the development of an electronic version of premenstrual syndrome charts, pain charts and an alternative menstrual pictogram) for symptometrics. He has received payment from Asarina Pharma for consultancy work and to act as Chief Investigator for a randomized controlled trial on premenstrual syndrome, and from Bayer for consulting services and expert testimony for the licensing of, and lectures on, OC Yaz. He has also been an unpaid Chair for the International Society for Premenstrual Disorders (ISPMD) and has received payment for intellectual property issues unrelated to the work in this manuscript. C.S. and C.G. are full-time employees of Bayer AG.